Swedish and Italian Researchers Seek Funding for Development of Promising Mesothelioma Treatment
Developing a new, effective treatment for mesothelioma is not a project that is undertaken lightly. The costs and effort that go into the work are tremendous for even the largest pharmaceutical companies. But for smaller companies the costs can be prohibitive. One Swedish company, however, is confident in its latest research and is actively seeking investors to help fund development of a novel therapy targeting both pleural and peritoneal mesothelioma.